XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 30.98

+3.9%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (16223)	7/7/2003 9:46:43 AM
From: aknahow	Read Replies (1) of 17367

How can you say "still quite good"? Would you please provide a source for these projections? While it may be tempering, I am not sure if you are saying the prospects of a Raptiva launch are tempering BGEN projections of Amevive sales? Or are you saying the weak projections of Amevive sales make investors have second thoughts about Raptiva sales? Who said this. "analyst covering Dna mentioned it as the ugly duck"? Don't doubt it was said I just want to know more. tia

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next